An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Lipegfilgrastim (Primary)
- Indications Breast cancer; Male breast cancer
- Focus Adverse reactions
- 22 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 12 Dec 2015 Trial design presented at the 38th Annual San Antonio Breast Cancer Symposium.
- 21 Aug 2015 New trial record